sirolimus售价多少?
Sirolimus is a macrolide compound and is a specific inhibitor of mTOR. It can inhibit mTOR activity, block the cell cycle progression from G1 phase to S phase, and inhibit the release of vascular endothelial growth factor and the proliferation of endothelial progenitor cells and keratinocytes. There are currently a large number of literature reports on its application in the treatment of a variety of diseases, including patients undergoing kidney transplantation, hereditary skin diseases (such as TSC, Birt Hogg Dubé syndrome, Cowden disease, port wine stain, hemangioma, etc.), skin tumors (such as melanoma, non-melanoma cell skin tumors, cutaneous T-cell lymphoma, Kaposi sarcoma, etc.), autoimmune or inflammatory diseases (such as systemic sclerosis, chronic oral lichen planus, etc.).
So, how much does such effective sirolimus cost?
According to the official display of the China Medical Information Query Platform, the reference price of this drug is 143.00$~2739.00$. Normally, patients can buy a box of the small-sized medicines they need for about $500.
At present, Leipamin has been included in the medical insurance catalog and belongs to the Class B drug of medical insurance. This also means that when patients purchase the drug in China, they can rely on medical insurance to reimburse part of the cost, thereby reducing their out-of-pocket expenses and reducing their own financial burden. Normally, the medical insurance reimbursement ratio is around 70% to 80%. However, it is affected by the medical insurance policies of various regions and other factors, so there will be certain differences in the final reimbursement ratio. Specific patients can consult the relevant departments.
During the actual treatment process, patients should be treated in institutions equipped with appropriate laboratories and auxiliary medical facilities and personnel. It is recommended to take sirolimus (sirolimus) in combination with cyclosporine and corticosteroids, once a day, regularly with or without food.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)